Yanling Zhao

2.3k total citations · 1 hit paper
48 papers, 1.5k citations indexed

About

Yanling Zhao is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Yanling Zhao has authored 48 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 19 papers in Neurology and 12 papers in Cancer Research. Recurrent topics in Yanling Zhao's work include Neuroblastoma Research and Treatments (18 papers), Ubiquitin and proteasome pathways (11 papers) and Cell death mechanisms and regulation (9 papers). Yanling Zhao is often cited by papers focused on Neuroblastoma Research and Treatments (18 papers), Ubiquitin and proteasome pathways (11 papers) and Cell death mechanisms and regulation (9 papers). Yanling Zhao collaborates with scholars based in China, United States and Taiwan. Yanling Zhao's co-authors include Jianhua Yang, Zhenghu Chen, Yihui Fan, H Zhang, Sanjeev A. Vasudevan, Jed G. Nuchtern, Zhongcheng Shi, Xin Xu, Eugene S. Kim and Jiaxiong Lu and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Yanling Zhao

48 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fusobacterium nucleatum Secretes Outer Membrane Vesicles and Promotes Intestinal Inflammation

2021 191 citations Melinda A. Engevik, Heather A. Danhof et al. mBio profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yanling Zhao China	22	1.0k	385	348	240	190	48	1.5k
Soheil Naderi Norway	24	819 0.8×	414 1.1×	166 0.5×	219 0.9×	145 0.8×	59	1.5k
Parag P. Shah United States	27	1.0k 1.0×	258 0.7×	297 0.9×	112 0.5×	75 0.4×	62	1.8k
Yan Cui China	19	900 0.9×	342 0.9×	182 0.5×	218 0.9×	98 0.5×	48	1.6k
Atieh Pourbagheri‐Sigaroodi Iran	22	638 0.6×	277 0.7×	214 0.6×	285 1.2×	111 0.6×	59	1.4k
Alexander V. Bocharov United States	22	954 0.9×	318 0.8×	264 0.8×	503 2.1×	63 0.3×	41	2.1k
Hong Lv China	20	716 0.7×	192 0.5×	493 1.4×	183 0.8×	62 0.3×	85	1.4k
Hiroaki Uranishi Japan	14	671 0.7×	273 0.7×	184 0.5×	145 0.6×	58 0.3×	24	1.1k
Lan Wang China	25	905 0.9×	274 0.7×	338 1.0×	367 1.5×	36 0.2×	74	1.8k
Dan Chen China	18	873 0.9×	241 0.6×	332 1.0×	229 1.0×	55 0.3×	77	1.5k

Countries citing papers authored by Yanling Zhao

Since Specialization

Citations

This map shows the geographic impact of Yanling Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanling Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanling Zhao more than expected).

Fields of papers citing papers by Yanling Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanling Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanling Zhao. The network helps show where Yanling Zhao may publish in the future.

Co-authorship network of co-authors of Yanling Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Yanling Zhao. A scholar is included among the top collaborators of Yanling Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanling Zhao. Yanling Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Yang, Yanling Zhao, Zhongcheng Shi, et al.. (2022). ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo. Cancers. 14(22). 5534–5534. 9 indexed citations

Zou, Chong, Hong Ding, Rui Gao, et al.. (2021). [Consensus on collaborative ethical review of multi-center clinical trials of new drugs of traditional Chinese medicine (version 1.0)].. PubMed. 46(7). 1696–1700. 1 indexed citations

Engevik, Melinda A., Heather A. Danhof, Wenly Ruan, et al.. (2021). Fusobacterium nucleatum Secretes Outer Membrane Vesicles and Promotes Intestinal Inflammation. mBio. 12(2). 191 indexed citations breakdown →

Yuan, Wei-An, Jianyuan Tang, Rui Gao, et al.. (2021). [Expert consensus on key issues of quality control in clinical trials of new drugs of traditional Chinese medicine].. PubMed. 46(7). 1701–1705. 7 indexed citations

Xu, Weiwei, et al.. (2020). Overexpression of lncRNA Gm43050 alleviates apoptosis and inflammation response induced by sevoflurane treatment by regulating miR-640/ZFP91.. PubMed Central. 12(8). 4337–4346. 13 indexed citations

Yu, Yang, Yanling Zhao, Yihui Fan, et al.. (2019). Inhibition of Ubiquitin-Specific Protease 14 Suppresses Cell Proliferation and Synergizes with Chemotherapeutic Agents in Neuroblastoma. Molecular Cancer Therapeutics. 18(6). 1045–1056. 13 indexed citations

Chen, Zhenghu, Long Wang, Tianshu Yang, et al.. (2016). Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis. Scientific Reports. 6(1). 38011–38011. 29 indexed citations

Chen, Zhenghu, Yanling Zhao, Yang Yu, et al.. (2016). Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma. Oncotarget. 8(1). 1555–1568. 23 indexed citations

Chen, Zhenghu, Zhenyu Wang, Jonathan C. Pang, et al.. (2016). Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity. Scientific Reports. 6(1). 29090–29090. 62 indexed citations

10.

Li, Haoyu, Yongfeng Wang, Zhenghu Chen, et al.. (2016). Novel multiple tyrosine kinase inhibitor ponatinib inhibits bFGF-activated signaling in neuroblastoma cells and suppresses neuroblastoma growth in vivo. Oncotarget. 8(4). 5874–5884. 19 indexed citations

11.

Zhao, Yanling, Xiao Ma, Jiabo Wang, et al.. (2015). A System Review of Anti-fibrogenesis Effects of Compounds Derived from Chinese Herbal Medicine. Mini-Reviews in Medicinal Chemistry. 16(2). 163–175. 11 indexed citations

12.

Shi, Zhongcheng, Paul Labhart, Yanling Zhao, et al.. (2015). Context-specific role of SOX9 in NF-Y mediated gene regulation in colorectal cancer cells. Nucleic Acids Research. 43(13). 6257–6269. 51 indexed citations

13.

Wei, Shizhang, Jiabo Wang, Ruisheng Li, et al.. (2015). San-Cao Granule (三草颗粒) Ameliorates Hepatic Fibrosis through High Mobility Group Box-1 Protein/Smad Signaling Pathway. Chinese Journal of Integrative Medicine. 24(7). 502–511. 5 indexed citations

14.

Zhang, Huiyuan, Jun Dou, Yang Yu, et al.. (2014). mTOR ATP-competitive inhibitor INK128 inhibits neuroblastoma growth via blocking mTORC signaling. APOPTOSIS. 20(1). 50–62. 40 indexed citations

15.

Amet, Tohti, Daniel Byrd, Ningjie Hu, et al.. (2014). BST-2 Expression in Human Hepatocytes is Inducible by All Three Types of Interferons and Restricts Production of Hepatitis C Virus. Current Molecular Medicine. 14(3). 349–360. 27 indexed citations

16.

Fan, Yihui, Sanjeev A. Vasudevan, Roma H. Patel, et al.. (2013). TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy. APOPTOSIS. 18(10). 1224–1234. 39 indexed citations

17.

Fan, Yihui, Yi Shi, Shangfeng Liu, et al.. (2012). Lys48-linked TAK1 polyubiquitination at lysine-72 downregulates TNFα-induced NF-κB activation via mediating TAK1 degradation. Cellular Signalling. 24(7). 1381–1389. 27 indexed citations

18.

Liang, Li, Yihui Fan, Jin Cheng, et al.. (2012). TAK1 ubiquitination regulates doxorubicin-induced NF-κB activation. Cellular Signalling. 25(1). 247–254. 42 indexed citations

19.

Wang, Jiabo, Yonggang Ma, Cheng Jin, et al.. (2009). [Study toxicity-attenuating effect and dose-toxicity relationship of rhubarb by processing based on correspondence analysis].. PubMed. 34(19). 2498–502. 8 indexed citations

20.

Xiao, Xiaohe, Dan Yan, Cheng Jin, & Yanling Zhao. (2008). [Increasing dosage: a momentous proposition to improve therapeutic efficacy of traditional Chinese medicine].. PubMed. 33(3). 229–32. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact